The 7 analysts offering 12-month price forecasts for Syndax Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 35.00 and a low estimate of 26.00. The median estimate represents a +25.56% increase from the last price of 24.69.
The current consensus among 8 polled investment analysts is to Buy stock in Syndax Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.64
Reporting Date Nov 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.